ENDRA Life Sciences Inc (NDRA)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.42M | -3.31M | -2.94M | -2.99M | -3.06M | -1.46M | -2.78M | -2.23M |
Pre Tax Income | -3.44M | -3.29M | -2.94M | -2.56M | -3.1M | -1.46M | -2.78M | -2.23M |
Net Income | -3.44M | -3.29M | -2.94M | -2.56M | -3.1M | -1.46M | -2.78M | -2.23M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -3.44M | -3.29M | -2.94M | -2.56M | -3.03M | -1.46M | -2.78M | -2.23M |
EBITDA | -3.39M | -3.28M | -2.9M | -2.96M | -3.03M | -1.44M | -2.77M | -2.22M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 516k | 352k | 6k | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.79M | -4.63M | -8.73M | -10.84M | -11.5M | -11.5M | -13.16M | -10.52M |
Pre Tax Income | -2.78M | -5.38M | -9.8M | -13.31M | -11.73M | -11.23M | -13.18M | -10.06M |
Net Income | -2.78M | -5.38M | -9.8M | -17.53M | -12.12M | -11.35M | -13.18M | -10.06M |
Preferred Dividends | 0 | 0 | 0 | -4.22M | -395k | -121k | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.096 | -1.371 | -1.32 | -2.081 | -0.356 | -0.266 | -3.819 | -1.157 |
EBIT | -2.77M | -5.38M | -9.51M | -10.95M | -11.49M | -11.23M | -13.18M | -10.06M |
EBITDA | -1.73M | -4.57M | -8.66M | -10.76M | -11.4M | -11.38M | -13.06M | -10.4M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.